Clinical Trials Browser

Phase 2 × Interventional × Virus Diseases × Clear all

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT04482933 2026-02-10

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

Phase 2 Withdrawn

CNS

Brain Neoplasms, Glioblastoma, Glioma, Herpes Simplex, Neoplasms, Virus Diseases

NCT02532452 2025-12-16

Third Party Viral Specific T-cells (VSTs)

Phase 2 Recruiting

750 enrolled

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT03487549 2024-11-27

COVE-1

Phase 2 Completed

56 enrolled 29 charts

DNA Virus Infections, Skin Diseases, Skin Diseases, Infectious, Tumor Virus Infections, Virus Diseases, Warts, Skin Diseases, Viral, Papillomavirus Infections

NCT03981822 2024-11-27

CARE-1

Phase 2 Completed

105 enrolled 24 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Skin Diseases, Skin Diseases, Infectious, Virus Diseases, Warts, Sexually Transmitted Diseases, Viral, Skin Diseases, Viral, Papillomavirus Infections

NCT02482428 2021-01-05

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Phase 2 Completed

88 enrolled 10 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

NCT02868242 2020-03-02

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Phase 2 Completed

19 enrolled 14 charts

Hepatitis C, Liver Diseases, Virus Diseases, Hepatitis C, Chronic

NCT01136395 2019-10-08

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Phase 2 Completed

85 enrolled

Virus Diseases, Epstein-Barr Virus Infections

NCT02724254 2018-07-20

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Phase 2 Completed

218 enrolled

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

Clinical Trials

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

Third Party Viral Specific T-cells (VSTs)

COVE-1

CARE-1

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients